Sells portable and home oxygen concentrators, airway-clearing devices and sleep-apnea masks to patients, home medical equipment providers and distributors.
10-K for FY2025, filed Feb 27, 2026Inogen, Inc. is a medical technology business that primarily focuses on respiratory health. We develop, manufacture, and market innovative…View ↗
We expanded our addressable market opportunity into the airway clearance market with the acquisition of Physio-Assist in September 2023.…View ↗
Stationary oxygen concentratorsView ↗
Airway clearance devicesView ↗
CPAP masksView ↗
In the United States, we market and distribute our products directly to consumers through a wide variety of direct-to-consumer sales and…View ↗
Money comes mainly from product sales and rentals. Some customers pay before products are delivered; rentals run in one-month periods, with payment from insurers, patients or Medicare.
10-K for FY2025, filed Feb 27, 2026We generate revenue primarily from sales and rentals of our products. Our products consist of our proprietary line of oxygen concentrators…View ↗
The payment terms and conditions of customer contracts vary by customer type and the products and services offered. For certain products or…View ↗
We recognize equipment rental revenue over the non-cancelable lease term, which is one month, less estimated adjustments, per ASC…View ↗
We also rent products directly to consumers for insurance reimbursement, and collect payment from private insurance payers, patients, or…View ↗
$348.7M
10-K for FY2025, filed Feb 27, 2026
$348.7M ↗
Home medical equipment providers, distributors and resellers buy on credit, while consumers buy directly, usually in advance. Inogen also rents directly to consumers and collects from private insurers, patients and Medicare; internationally, it sells through distributors and resellers and directly to large accounts.
10-K for FY2025, filed Feb 27, 2026We primarily sell our products to traditional home medical equipment providers, distributors, and resellers in the United States and in…View ↗
We also rent products directly to consumers for insurance reimbursement, and collect payment from private insurance payers, patients, or…View ↗
Approximately 39.8% of our total revenue was from outside the United States in 2025. We sell through distributors, resellers, and home…View ↗
No. It lost $22.7M in FY2025.
10-K for FY2025, filed Feb 27, 2026
−$30.2MView ↗
10-K for FY2025, filed Feb 27, 2026
−$22.7MView ↗
10-K for FY2025, filed Feb 27, 2026
−$13.7MView ↗
10-Q for Q2 FY2026, filed Aug 7, 2026
−$3.9MView ↗
8-K, filed Aug 6, 2026
Raised adjusted EBITDA guidance for the full year 2026 to approximately $4.0 million, representing a 48.1% increase from adjusted EBITDA of…View ↗
8-K, filed Mar 30, 2026
Jason Richardson has been appointed Chief Financial Officer, effective April 6, 2026. Mr. Richardson succeeds Michael Bourque, who will…View ↗
Flat. Revenue was $348.7M in FY2025, about the same as the $358M of FY2021.
Broader product range
The older product description centered on portable oxygen concentrators; the latest also describes stationary oxygen concentrators, airway-clearing devices and sleep-apnea masks.
10-K for FY2022, filed Feb 24, 2023
Competes with Rhythm Healthcare, Caire Medical, Drive DeVilbiss Healthcare, O2 Concepts, React Health, Nidek Medical Products, Precision Medical, 3B Medical, SysMed, GCE Healthcare, and Respironics
10-K for FY2025, filed Feb 27, 2026Our significant manufacturing competitors are Rhythm Healthcare, Caire Medical (a subsidiary of NGK Spark Plug Co., Ltd.), Drive DeVilbiss…View ↗
Loading...